Delivery Order SPE2DB22D3004-SPE2DB25FPG22
Award Date
1/27/25
Potential Completion Date
1/28/25
Potential Value
$3.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,329.56, is for the delivery of LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML, a medical product used for healthcare purposes. The contract has an ultimate completion date of February 26, 2025 and is a firm fixed-price delivery order contract. The contract was not set aside for any specific...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,015.06, is for the delivery of LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML, a pharmaceutical product. The contract has an ultimate completion date of March 27, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no indication of any set-aside requirements for this award....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $2,589.67, is for the delivery of LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML, a specialty medication used to treat diabetes. The contract has an ultimate completion date of March 17, 2025 and is a firm fixed-price contract. The contract is not designated as a set-aside. AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,292.59, is for the delivery of LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML, a pharmaceutical product, and has an ultimate completion date of April 14, 2025. This appears to be a delivery order issued under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through...
This is a federal contract award made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,379.94, is a delivery order for LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML. It has a completion date of February 14, 2025 and is a firm fixed price contract. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp is the prime contractor and holds a significant Indefinite...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $8,281.33 firm fixed-price delivery order is for the supply of LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML, a pharmaceutical product. The award has an ultimate completion date of December 11, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,405.49, is for the delivery of Liraglutide 3-Pak 18 mg/3 ml 3 ml, a medication used to treat diabetes. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 11, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,093.04, is for the delivery of Liraglutide 3-Pak 18 mg/3 ml 3 ml medical supplies. The contract has a firm fixed price pricing type and an ultimate completion date of March 26, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $5,022.12 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LIRAGLUTIDE 3-PAK 18 MG/3 ML 3ML medical products. This contract is not designated as a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical. The IDC provides a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,629.46, is for the delivery of Liraglutide 3-pak 18 mg/3 ml 3 ml, a diabetes medication. The contract has a firm fixed price and an ultimate completion date of July 18, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...